Angelina M Hughes, | |
695 Oakdale Dr, Elm Mott, TX 76640-3625 | |
(469) 571-5920 | |
Not Available |
Full Name | Angelina M Hughes |
---|---|
Gender | Female |
Speciality | Licensed Practical Nurse |
Location | 695 Oakdale Dr, Elm Mott, Texas |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1508484080 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
164W00000X | Licensed Practical Nurse | 324008 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Angelina M Hughes, 695 Oakdale Dr, Elm Mott, TX 76640-3625 Ph: (469) 571-5920 | Angelina M Hughes, 695 Oakdale Dr, Elm Mott, TX 76640-3625 Ph: (469) 571-5920 |
News Archive
A new paper by William W Bostock from the School of Government, University of Tasmania, analysing the debate between the psychiatric profession and the Australian government over collective depression syndrome found among asylum-seeking detainees, has been published in the Dove Medical Press journal: Psychology Research and Behavior Management.
Today Intercell AG announced that it has agreed with Novartis to advance Intercell's investigational Pseudomonas aeruginosa vaccine into a confirmatory clinical efficacy trial in ventilated ICU patients.
Nova Southeastern University College of Osteopathic Medicine's (NSU-COM) Florida Coastal Geriatric Resources, Education, and Training Center (GREAT GEC) will host the 6th Annual Interprofessional Geriatrics Training Institute on Feb. 15 and 16.
Micromet, Inc., a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced the publication of a poster with new data from its ongoing phase 1 clinical trial of its product candidate blinatumomab in patients with non-Hodgkin's lymphoma (NHL) at the 51ST Annual Meeting of the American Society of Hematology (ASH) in New Orleans, Louisiana.
The most powerful genetic analysis of the DNA codes of over 40,000 women - including those with breast cancer as well as those without the disease, has uncovered five common genetic variants that increase an individual's risk for breast cancer.
› Verified 6 days ago